Aggressive Pharmacotherapy in Reproductive Medicine. Pregnancy and Medicines (Author’s Perspective)

The article discusses the issues of polypharmacy and unjustified prescribing in pregnant women. The author— Honoured Scientist of the Russian Federation, Corresponding Member of the Russian Academy of Sciences, Doctor of Medical Sciences, Full Professor, and Head of the Department for Obstetrics and...

Full description

Saved in:
Bibliographic Details
Main Author: V. E. Radzinskiy
Format: Article
Language:Russian
Published: Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2024-10-01
Series:Безопасность и риск фармакотерапии
Subjects:
Online Access:https://www.risksafety.ru/jour/article/view/434
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849252392137129984
author V. E. Radzinskiy
author_facet V. E. Radzinskiy
author_sort V. E. Radzinskiy
collection DOAJ
description The article discusses the issues of polypharmacy and unjustified prescribing in pregnant women. The author— Honoured Scientist of the Russian Federation, Corresponding Member of the Russian Academy of Sciences, Doctor of Medical Sciences, Full Professor, and Head of the Department for Obstetrics and Gynaecology with a Course on Perinatology at the Institute of Medicine of the Peoples’ Friendship University of Russia named after Patrice Lumumba, Viktor E. Radzinskiy — questions the established practice of unnecessary hospitalisation of pregnant women without clinical indications and prescribing them numerous medicinal products, including antimicrobials, hormones, and antispasmodics. In most cases, pregnancy does not require medical intervention. The widespread use of progestogens in patients with threatened miscarriage lacks an evidence base. Antispasmodics, such as papaverine, are ineffective in threatened preterm labour. The author calls for a rational approach to prescribing medicinal products to pregnant women based on current clinical practice guidelines and the “do no harm” maxim. Viktor E. RADZINSKIY emphasises the need to follow clinical protocols and ensure physicians are informed about the evidence for the use of medicinal products in pregnancy to prevent polypharmacy and adverse consequences.
format Article
id doaj-art-79215e779d01451ba00f7b80c69a7e8e
institution Kabale University
issn 2312-7821
2619-1164
language Russian
publishDate 2024-10-01
publisher Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
record_format Article
series Безопасность и риск фармакотерапии
spelling doaj-art-79215e779d01451ba00f7b80c69a7e8e2025-08-20T03:56:38ZrusMinistry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»Безопасность и риск фармакотерапии2312-78212619-11642024-10-0112324725210.30895/2312-7821-2024-434347Aggressive Pharmacotherapy in Reproductive Medicine. Pregnancy and Medicines (Author’s Perspective)V. E. Radzinskiy0Peoples’ Friendship University of Russia named after Patrice LumumbaThe article discusses the issues of polypharmacy and unjustified prescribing in pregnant women. The author— Honoured Scientist of the Russian Federation, Corresponding Member of the Russian Academy of Sciences, Doctor of Medical Sciences, Full Professor, and Head of the Department for Obstetrics and Gynaecology with a Course on Perinatology at the Institute of Medicine of the Peoples’ Friendship University of Russia named after Patrice Lumumba, Viktor E. Radzinskiy — questions the established practice of unnecessary hospitalisation of pregnant women without clinical indications and prescribing them numerous medicinal products, including antimicrobials, hormones, and antispasmodics. In most cases, pregnancy does not require medical intervention. The widespread use of progestogens in patients with threatened miscarriage lacks an evidence base. Antispasmodics, such as papaverine, are ineffective in threatened preterm labour. The author calls for a rational approach to prescribing medicinal products to pregnant women based on current clinical practice guidelines and the “do no harm” maxim. Viktor E. RADZINSKIY emphasises the need to follow clinical protocols and ensure physicians are informed about the evidence for the use of medicinal products in pregnancy to prevent polypharmacy and adverse consequences.https://www.risksafety.ru/jour/article/view/434pregnancypolypharmacymedicinal productsrational prescribingclinical protocolsprogestogensantispasmodicsantibioticsevidence-based medicine
spellingShingle V. E. Radzinskiy
Aggressive Pharmacotherapy in Reproductive Medicine. Pregnancy and Medicines (Author’s Perspective)
Безопасность и риск фармакотерапии
pregnancy
polypharmacy
medicinal products
rational prescribing
clinical protocols
progestogens
antispasmodics
antibiotics
evidence-based medicine
title Aggressive Pharmacotherapy in Reproductive Medicine. Pregnancy and Medicines (Author’s Perspective)
title_full Aggressive Pharmacotherapy in Reproductive Medicine. Pregnancy and Medicines (Author’s Perspective)
title_fullStr Aggressive Pharmacotherapy in Reproductive Medicine. Pregnancy and Medicines (Author’s Perspective)
title_full_unstemmed Aggressive Pharmacotherapy in Reproductive Medicine. Pregnancy and Medicines (Author’s Perspective)
title_short Aggressive Pharmacotherapy in Reproductive Medicine. Pregnancy and Medicines (Author’s Perspective)
title_sort aggressive pharmacotherapy in reproductive medicine pregnancy and medicines author s perspective
topic pregnancy
polypharmacy
medicinal products
rational prescribing
clinical protocols
progestogens
antispasmodics
antibiotics
evidence-based medicine
url https://www.risksafety.ru/jour/article/view/434
work_keys_str_mv AT veradzinskiy aggressivepharmacotherapyinreproductivemedicinepregnancyandmedicinesauthorsperspective